[Endovascular surgery for acute mesenteric ischemia]

A I Khripun1, A B Mironkov2, A D Pryamikov2

  • 1Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Department of Surgery and Endoscopy of the Faculty of Additional Professional Education, Moscow, Russia.

Khirurgiia
|April 10, 2020
PubMed
Abstract

Insights

Endovascular treatment successfully restored superior mesenteric artery blood flow in 93% of acute mesenteric ischemia patients. However, high mortality persists, primarily due to reperfusion syndrome.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Gastroenterology

Background:

  • Acute mesenteric ischemia (AMI) is a critical condition with high mortality.
  • Endovascular techniques offer a minimally invasive approach to revascularization.

Purpose of the Study:

  • To evaluate the outcomes of endovascular treatment for AMI.
  • To assess the efficacy and safety of endovascular revascularization of the superior mesenteric artery.

Main Methods:

  • Retrospective analysis of 15 patients with AMI who underwent endovascular treatment.
  • Details of endovascular intervention techniques and indications are described.
  • Causes of AMI included thromboembolism, thrombosis, and stenosis of the superior mesenteric artery.

Main Results:

  • Successful blood flow restoration in the superior mesenteric artery was achieved in 14 out of 15 patients (93%).
  • Intestinal viability was preserved in most patients (93%), with limited need for bowel resection.
  • The in-hospital mortality rate was 47%, with reperfusion syndrome being the leading cause of death.

Conclusions:

  • Endovascular treatment can effectively restore mesenteric blood flow and preserve bowel viability in AMI.
  • High mortality remains a significant challenge, largely attributed to reperfusion syndrome.
  • Developing novel strategies for preventing and managing reperfusion syndrome is crucial for improving AMI outcomes.